Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemia

Leukemia & Lymphoma
Uri RozovskiZeev Estrov

Abstract

Unlike normal B-cells, and similar to fat cells, chronic lymphocytic leukemia (CLL) cells aberrantly express lipoprotein lipase (LPL), which contributes to free fatty acids (FFAs) metabolism. Here we show that, in CLL cells, the B-cell receptor (BCR) inhibitor ibrutinib reduced LPL mRNA and protein levels and inhibited FFA metabolism in vitro. Likewise, in CLL cells from ibrutinib-treated patients, FFA metabolism was reduced and eventually stopped. Because ibrutinib disrupts CLL cells' ability to use FFAs for energy production, and because various BCR-dependent cellular functions rely on a continuous supply of chemical energy, ibrutinib interrupts several pathways imperative for cellular function in CLL cells.

References

Dec 17, 2002·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·James R MeadDipak P Ramji
Feb 8, 2006·Annals of the New York Academy of Sciences·Nicholas ChiorazziEmilia Albesiano
Oct 12, 2010·PPAR Research·Maryam RakhshandehrooSander Kersten
Oct 10, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ranjana H AdvaniNathan H Fowler
Apr 26, 2013·Leukemia & Lymphoma·Cecilia AbreuPablo Oppezzo
Jun 21, 2013·The New England Journal of Medicine·John C ByrdSusan O'Brien
Oct 9, 2014·Oncotarget·Lyubov ZaitsevaStuart A Rushworth
Mar 4, 2015·Molecular Cancer Research : MCR·Uri RozovskiZeev Estrov
Dec 8, 2015·The New England Journal of Medicine·Jan A BurgerUNKNOWN RESONATE-2 Investigators
Dec 9, 2015·Leukemia & Lymphoma·Uri RozovskiZeev Estrov
Oct 1, 2016·Expert Opinion on Drug Metabolism & Toxicology·Prithviraj BoseMichael J Keating

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Related Papers

Clinical Advances in Hematology & Oncology : H&O
Lloyd E Damon
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
F PanN Sengupta
© 2022 Meta ULC. All rights reserved